Ifosfamide, carboplatin, etoposide with or without bortezomib in patients with relapsed/refractory Hodgkin lymphoma: Results of a randomized phase II trial Journal Article
| Authors: | Karuturi, M.; Younes, A.; Fayad, L.; Kwak, L.; Pro, B.; Shah, J.; Oki, Y.; Simien, R.; Liboon, M. J.; Hutto, T.; Feng, L.; Horowitz, S.; Nieto, Y.; Anderlini, P.; Alousi, A.; Popat, U.; Medeiros, L. J.; Miranda, R.; Fanale, M. |
| Article Title: | Ifosfamide, carboplatin, etoposide with or without bortezomib in patients with relapsed/refractory Hodgkin lymphoma: Results of a randomized phase II trial |
| Journal Title: | Leukemia and Lymphoma |
| Volume: | 57 |
| Issue: | 2 |
| ISSN: | 1042-8194 |
| Publisher: | Taylor & Francis Group |
| Date Published: | 2016-01-01 |
| Start Page: | 445 |
| End Page: | 447 |
| Language: | English |
| DOI: | 10.3109/10428194.2015.1032966 |
| PROVIDER: | scopus |
| PUBMED: | 25804933 |
| PMCID: | PMC5215977 |
| DOI/URL: | |
| Notes: | Letter -- Export Date: 3 February 2016 -- Source: Scopus |
